Xianmin Song, MD
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALL (NCT06930105) | Xianmin Song, MD | 2025-09-01 |
| RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL. (NCT06468267) | Xianmin Song, MD | 2024-07-15 |
| Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies (NCT05583175) | Xianmin Song, MD | 2022-11-01 |
| Next Generation Sequencing（NGS）Monitors Minimal Residual Disease（MRD）in Allo-PBSCT Patients (NCT04126967) | Xianmin Song, MD | 2019-10-01 |
Track Xianmin Song, MD automatically
Every clearance here is in the API, with alerts when new ones post.